Day: April 27, 2022

BEVERLY HILLS, Calif., April 27, 2022 /PRNewswire/ — Galliott Capital Advisors, the independent wealth advisory firm, today announced that Robert Mourad has joined the firm in the new executive role of Chief Portfolio Strategist. Mr. Mourad will also serve as Executive Director of Products & Services, responsible for working directly with the firm’s clients on portfolio construction and partnering with Galliott’s advisors on growing their business.

Galliott, founded in 2020 by Antoine Souma, focuses on the financial and investment needs of international clients, primarily in Europe, Mexico, and the Middle East. The hiring of Mr. Mourad is part of a strategic plan to significantly grow the firm’s assets under management and attract additional entrepreneurial advisors who seek the benefits of working in a collaborative, independent environment.

“Having known Robert Mourad for more than 20 years, I knew that his knowledge of the industry, the markets, and the full array of products we can deliver would make Robert a tremendous asset to our clients and advisors alike,” said Mr. Souma, Galliott’s Managing Partner.

Mr. Mourad joined Galliott from UBS Financial Services after a 26+ year career, during which he held several roles in investment advisory, portfolio strategy, and wealth planning, culminating in his role as Advisory Sales Consultant for UBS’ Southwest Region. He holds multiple industry designations, including: CERTIFIED FINANCIAL PLANNER™ (CFP®); Certified Exit Planning Advisor (CEPA®); Certified Private Wealth Advisor (CPWA®); Certified Investment Management Analyst (CIMA®); and Chartered Sustainable, Responsible, Impact Investments Counselor (CSRIC®). Mr. Mourad earned his MBA at Pepperdine University and his BS in Business Administration Finance at California State University Long Beach.

“Our international clients have particular needs that are often underserved by larger financial services firms,” said Mr. Mourad.  They require not only more skilled and specialized advisors, but also a broader range of investment vehicles to accommodate their portfolio objectives. As an independent firm working in a true open architecture, Galliott can deliver best-in-class products, services and analytics from our growing list of resource partners.”

About Galliott Capital Advisors

Galliott Capital Advisors is an independent wealth advisory firm, providing family office solutions to sophisticated entrepreneurs and their families. A globally oriented practice, with international clients primarily in Europe, Mexico, and the Middle East, Galliott has managed the complex, multigenerational financial needs of cosmopolitan clients for more than 20 years. Galliott offers a private banking level of personalized service, integrity, a tireless work ethic, and discretion. To learn more, visit www.galliott.com.

The Firm’s financial Advisors are also registered representatives of Insigneo Securities, LLC, an unaffiliated broker dealer, www.insigneo.com

Media Contact:
Lauren Colonna lcolonna@oviscreative.com

Logo – https://mma.prnewswire.com/media/1804393/Galliott_logo_color_big_Logo.jpg

IRVINE, Calif., April 27, 2022 /PRNewswire/ — Zymo Research and Star Array today announced Zymo Research’s strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore. The investment allows Zymo Research and Star Array to combine Zymo Research’s nucleic acid purification and assay technologies with Star Array’s engineering and automation expertise to expand into emerging For Research Use Only (FRUO) and diagnostic markets including Point-of-Care testing (POCT).

Star Array’s focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology. It manufactures and markets various genetic analyzers including its premier product, XDive^™, a superfast qPCR platform, with related kits and software. During the COVID-19 outbreak, Star Array developed a test for SARS-CoV-2 detection utilizing its XDive^™ system. The entire process from sample-to-answer takes less than 45 minutes and the system can be used in any clinical environment. Star Array is currently working through the Emergency Use Authorization (EUA) process with the U.S. Food and Drug Administration (FDA) through the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx^®) program.

Zymo Research, since its inception in 1994, is well known for its DNA/RNA extraction and assay technologies. Its goal has been to develop more efficient sample collection kits and devices that simplify and reduce the time needed to isolate nucleic acids in the laboratory. Zymo Research will be partnering with Star Array to develop ready-made cassettes containing the necessary reagents for Star Array’s COVID-19 test kit as well as future POCT.

“Star Array’s powerful PCR instrumentation places them at the forefront of PCR technology with their XDive^™ PCR system that can complete a typical 40-cycle multiplex qPCR run in 5-7 minutes. When coupled with Star Array’s system, Zymo Research’s DNA/RNA purification reagents and nucleic acid-based assays will facilitate a straightforward Sample-In/Answer-Out workflow. Through our investment in Star Array we will develop products targeting POCT in the global marketplace,” said Marc Van Eden, Vice President of Business Development at Zymo Research.

“Zymo Research and Star Array have both built businesses at the intersection of science and technology and we share a vision of ultrafast PCR technology that will enable POC PCR tests to be analyzed in just minutes in doctor’s offices, laboratories, and hospitals. Together we strive to build even more POCT products in the future,” said Dr. Yanhui Liu, Vice President of Star Array Pte. Ltd.

To learn more about Zymo Research’s DNA/RNA extraction and assay technologies visit their website. For more information about Star Array’s technology, click here: https://www.star-array.com/research-tools.

About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-of-the-art molecular biology tools since 1994. The company’s vision “The Beauty of Science is to Make Things Simple” is reflected in all of its products, from epigenetics to DNA/RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, diagnostic devices, and Next-Generation Sequencing (NGS) technologies that are high quality and simple to use. Follow Zymo Research on Facebook, LinkedIn, Twitter, and Instagram.

About Star Array Pte Ltd
Star Array is a leading developer of super-fast on-site genetic testing based on novel integrated sample preparation and qPCR processes. The company focuses on superfast nucleic acid amplification and extraction technologies. The demand for rapid response time has led Star Array to introduce superfast genetic testing for on-site precision treatment in doctor’s offices and routine laboratory testing in hospitals. Star Array is headquartered in Singapore. Contact Star Array at https://www.star-array.com.

Photo – https://mma.prnewswire.com/media/1805123/Zymo_Research_Star_Array.jpg

Logo – https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg

• Purchase commitment by the Government of Saudi Arabia by the Ministry of Finance to include award-winning Lucid Air and future Lucid models
• Among one of the largest-ever purchase commitments of its kind for sustainable electric vehicles
• Ten-year deal is part of Saudi Vision 2030 and Saudi Green Initiative to transform the Kingdom via sustainable transportation and technologies

NEWARK, Calif., April 26, 2022 /PRNewswire/ — Lucid Group, Inc. (NASDAQ: LCID), setting new standards with the longest-range, fastest-charging electric car on the market, today announced an agreement with the Government of Saudi Arabia, under which the Government will purchase up to 100,000 vehicles over a ten-year period, with an initial commitment to purchase 50,000 vehicles and an option to purchase up to an additional 50,000 vehicles over the same period.

“Delivering up to 100,000 Lucid electric vehicles in Saudi Arabia represents another pivotal moment in our acceleration of sustainable transportation worldwide,” said Peter Rawlinson, Lucid’s CEO and CTO. “We are delighted to be supporting Saudi Arabia in achieving its sustainability goals and net zero ambitions, as outlined by Saudi Vision 2030 and the Saudi Green Initiative, by bringing our advanced luxury EVs to Saudi Arabia.”

As part of the agreement, the Government of Saudi Arabia has pledged to purchase vehicles, including Lucid Air and other future models, built and assembled at Lucid’s existing Arizona factory and its future international manufacturing facility in Saudi Arabia. The order quantity is expected to range from 1,000 to 2,000 vehicles annually and increase to between 4,000 and 7,000 vehicles annually starting in 2025, with the delivery of the vehicles required to commence no later than the second quarter of 2023.

This will support the government’s drive to diversify the economy, provide thousands of highly skilled job opportunities and provide economic benefit to the Kingdom in line with Vision 2030.

The purchase price of the vehicles will be determined based on the lower of the standard retail price for the applicable vehicle in Saudi Arabia and the standard retail price for the applicable vehicle in the United States, plus the logistics and importation costs and other costs of delivering and homologating vehicles to regulations of Saudi Arabia.

About Lucid Group
Lucid’s mission is to inspire the adoption of sustainable energy by creating advanced technologies and the most captivating luxury electric vehicles centered around the human experience. The company’s first car, Lucid Air, is a state-of-the-art luxury sedan with a California-inspired design that features luxurious full-size interior space in a mid-size exterior footprint. Underpinned by race-proven battery technology and proprietary powertrains developed entirely in-house, Lucid Air was named the 2022 MotorTrend Car of the Year®. The Lucid Air Grand Touring features an official EPA estimated 516 miles of range or 1,050 horsepower. Customer deliveries of Lucid Air, which is produced at Lucid’s factory in Casa Grande, Arizona, are underway.

Media Contact
media@lucidmotors.com

Trademarks
This communication contains trademarks, service marks, trade names and copyrights of Lucid Group, Inc. and its subsidiaries and other entities, which are the property of their respective owners.

Forward Looking Statements
This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Lucid’s expectations regarding the Government of Saudi Arabia’s commitment to purchase vehicles, Lucid’s ability to produce and deliver vehicles, production and delivery volumes, timing of deliveries, pricing, future manufacturing capabilities and facilities, the promise of Lucid’s technology, and performance, range, and other features of the Lucid Air. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Lucid’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Lucid. These forward-looking statements are subject to a number of risks and uncertainties, including factors discussed under the heading “Risk Factors” in Lucid’s Annual Report on Form 10-K for the year ended December 31, 2021, as well as other documents Lucid has filed or will file with the Securities and Exchange Commission. If any of these risks materialize or Lucid’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Lucid presently does not know or that Lucid currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Lucid’s expectations, plans or forecasts of future events and views as of the date of this communication. Lucid anticipates that subsequent events and developments will cause Lucid’s assessments to change. However, while Lucid may elect to update these forward-looking statements at some point in the future, Lucid specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Lucid’s assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Photo – https://mma.prnewswire.com/media/1805222/Lucid_Air_1.jpg